CIBC Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Sell |
|
|||||
|
2025
Q1 | $17.6M | Buy |
|
|||||
|
2024
Q4 | $15.4M | Sell |
|
|||||
|
2024
Q3 | $18.6M | Buy |
|
|||||
|
2024
Q2 | $18.2M | Sell |
|
|||||
|
2024
Q1 | $15.8M | Buy |
|
|||||
|
2023
Q4 | $15.1M | Buy |
|
|||||
|
2023
Q3 | $14.3M | Buy |
|
|||||
|
2023
Q2 | $14.2M | Sell |
|
|||||
|
2023
Q1 | $13.8M | Buy |
|
|||||
|
2022
Q4 | $12.8M | Buy |
|
|||||
|
2022
Q3 | $8.91M | Buy |
|
|||||
|
2022
Q2 | $10.6M | Sell |
|
|||||
|
2022
Q1 | $11M | Buy |
|
|||||
|
2021
Q4 | $5.67M | Buy |
|
|||||
|
2021
Q3 | $5.64M | Buy |
|
|||||
|
2021
Q2 | $5.34M | Buy |
|
|||||
|
2021
Q1 | $4.08M | Buy |
|
|||||
|
2020
Q4 | $2.64M | Buy |
|
|||||
|
2020
Q3 | $1.81M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.12M | Sell |
|
|||||
|
2018
Q3 | $1.67M | Sell |
|
|||||
|
2018
Q2 | $3.02M | Sell |
|
|||||
|
2018
Q1 | $3.81M | Sell |
|
|||||
|
2017
Q4 | $4.74M | Buy |
|
|||||
|
2017
Q3 | $4.52M | Buy |
|
|||||
|
2017
Q2 | $4.07M | Buy |
|
|||||
|
2017
Q1 | $3.19M | Buy |
|
|||||
|
2016
Q4 | $1.43M | Sell |
|
|||||
|
2016
Q3 | $1.99M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $4.17M | Sell |
|
|||||
|
2013
Q4 | $5.5M | Sell |
|
|||||
|
2013
Q3 | $5.11M | Sell |
|
|||||
|
2013
Q2 | $9.38M | Buy |
|